Market Cap 2.25B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 16,225,400
Avg Vol 8,479,514
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 91%
Beta 1.17
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Jun. 30 at 4:50 AM
$ABCL Abcellera $ABCL maximum whales since IPO
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 30 at 2:51 AM
$ABCL If you haven't heard, it's a bull market in biotechs. Here's $ABCL
0 · Reply
Jwa68
Jwa68 Jun. 30 at 12:20 AM
$ABCL $GANX $COYA Nice day for all three and let us not forget $SLS. Bio is seeing big inflows and smaller names are all acquisition targets.
0 · Reply
1Knevrenuff
1Knevrenuff Jun. 29 at 11:10 PM
$ABCL 😎
0 · Reply
UncleTomFlorida
UncleTomFlorida Jun. 29 at 10:56 PM
$ABCL There are no negatives for this company. Abcellera is superbly managed - it is executing its business plannwith precision.
0 · Reply
EddieHayes
EddieHayes Jun. 29 at 10:15 PM
Relative Volume Scanner — 6/29 High activity names: • $ASTC — 7.2x • $FRSH — 2.0x • $ABCL — 1.9x • $AIIO — 1.9x • $LCID — 1.8x ZNTL — 1.7x •GEVO — 1.6x AGNC — 1.6x FCEL — 1.5x Key takeaway: This scan surfaces hundreds of names, but only a small subset typically translates volume spikes into tradable setups. Focus on structure, not just activity. I narrow these down to the cleanest opportunities. I often get asked why I don’t turn this into paid content, but for me it’s just a hobby. I’m not financially dependent on it, so I share it freely.
1 · Reply
SmartAlphaa
SmartAlphaa Jun. 29 at 9:30 PM
The momentum behind $ABCL is undeniable right now. If it can clear 8.50 dollars, we might be looking at a much bigger move. Ignore the hype, just watch the volume bars and the order flow. If it flips, be ready to exit. Trade it, don't marry it. $ABCL
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 29 at 9:29 PM
$ABCL Newcomers, I urge you to break free from your shepherd and exercise some discipline. Research $ABCL for yourself, and see beyond the superficial echoing sales pitch of short-term profits and price targets, etc... You have stumbled upon something truly rare, with tremendous long term value potential. Realizing this value is within your reach. Don't sell yourself short for pennies... Do a little reading on X! There are countless informative posts on ABCL that break down all of the ways the company is diversified, the upcoming catalysts, the management, the balance sheet, etc. Use AI to help you navigate the science concepts and any new vocabulary (who knows, you might even enjoy learning about the science). Empower yourselves. Don't be sheep!
0 · Reply
jacckkmm
jacckkmm Jun. 29 at 9:17 PM
$ABCL awesome day .. looking good and my other baby Kaching! $SLS
0 · Reply
NinjaXLightning
NinjaXLightning Jun. 29 at 8:43 PM
$EDIT $OUST $ABCL and $TREE working on monster reversals.
0 · Reply
Latest News on ABCL
AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 24 days ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 6 weeks ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 weeks ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 7 weeks ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 2 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 4 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 4 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 4 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 5 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 8 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 8 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 8 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 10 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 10 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 11 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 11 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon Jun. 30 at 4:50 AM
$ABCL Abcellera $ABCL maximum whales since IPO
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 30 at 2:51 AM
$ABCL If you haven't heard, it's a bull market in biotechs. Here's $ABCL
0 · Reply
Jwa68
Jwa68 Jun. 30 at 12:20 AM
$ABCL $GANX $COYA Nice day for all three and let us not forget $SLS. Bio is seeing big inflows and smaller names are all acquisition targets.
0 · Reply
1Knevrenuff
1Knevrenuff Jun. 29 at 11:10 PM
$ABCL 😎
0 · Reply
UncleTomFlorida
UncleTomFlorida Jun. 29 at 10:56 PM
$ABCL There are no negatives for this company. Abcellera is superbly managed - it is executing its business plannwith precision.
0 · Reply
EddieHayes
EddieHayes Jun. 29 at 10:15 PM
Relative Volume Scanner — 6/29 High activity names: • $ASTC — 7.2x • $FRSH — 2.0x • $ABCL — 1.9x • $AIIO — 1.9x • $LCID — 1.8x ZNTL — 1.7x •GEVO — 1.6x AGNC — 1.6x FCEL — 1.5x Key takeaway: This scan surfaces hundreds of names, but only a small subset typically translates volume spikes into tradable setups. Focus on structure, not just activity. I narrow these down to the cleanest opportunities. I often get asked why I don’t turn this into paid content, but for me it’s just a hobby. I’m not financially dependent on it, so I share it freely.
1 · Reply
SmartAlphaa
SmartAlphaa Jun. 29 at 9:30 PM
The momentum behind $ABCL is undeniable right now. If it can clear 8.50 dollars, we might be looking at a much bigger move. Ignore the hype, just watch the volume bars and the order flow. If it flips, be ready to exit. Trade it, don't marry it. $ABCL
1 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 29 at 9:29 PM
$ABCL Newcomers, I urge you to break free from your shepherd and exercise some discipline. Research $ABCL for yourself, and see beyond the superficial echoing sales pitch of short-term profits and price targets, etc... You have stumbled upon something truly rare, with tremendous long term value potential. Realizing this value is within your reach. Don't sell yourself short for pennies... Do a little reading on X! There are countless informative posts on ABCL that break down all of the ways the company is diversified, the upcoming catalysts, the management, the balance sheet, etc. Use AI to help you navigate the science concepts and any new vocabulary (who knows, you might even enjoy learning about the science). Empower yourselves. Don't be sheep!
0 · Reply
jacckkmm
jacckkmm Jun. 29 at 9:17 PM
$ABCL awesome day .. looking good and my other baby Kaching! $SLS
0 · Reply
NinjaXLightning
NinjaXLightning Jun. 29 at 8:43 PM
$EDIT $OUST $ABCL and $TREE working on monster reversals.
0 · Reply
Dbern7
Dbern7 Jun. 29 at 8:42 PM
$ABCL perfect close. Now watching for consolidation between here and $10.50. If it falls out of this we’re back in the $5-$7 range. Happy with this performance either way. Moving as expected
1 · Reply
KryptonResearch
KryptonResearch Jun. 29 at 8:34 PM
AI-enabled healthcare/research is the most obvious massive winner… $ABCL $SLS $RXRX $IBRX $TEM etc… We take a look at a lesser known name in this space, with similar, if not greater upside potential given their ownership of the data layer. This is the next big sector, we have our pick, but there are so many names that will pay well. https://kryptonresearch.substack.com/p/blood-money
0 · Reply
Stocktradesmoon
Stocktradesmoon Jun. 29 at 8:09 PM
$ABCL Monthly chart looks very explosive on this name. Volume speaks for itself. Just a reminder not to sleep on this name.
0 · Reply
DeMampCamp
DeMampCamp Jun. 29 at 8:05 PM
$ABCL Tremendous close, it wasn't wild, we weren't hanging on by a thread, we closed above $8 and it was extremely uneventful and I loved every minute of it! Cheers to a very successful day, folks!
1 · Reply
Money_maker777
Money_maker777 Jun. 29 at 8:03 PM
$ABCL Closed above 8 😀
0 · Reply
Jawdoc
Jawdoc Jun. 29 at 7:40 PM
https://stocktwits.com/news-articles/markets/equity/why-did-sls-mrna-abcl-stocks-surge-to-52-week-highs-last-week/cZ1Bw5KR7hb $ABCL
0 · Reply
AdamURAtoFookingNeptune
AdamURAtoFookingNeptune Jun. 29 at 7:28 PM
$ABCL dang nice patience payin off for yall maybe
0 · Reply
DeMampCamp
DeMampCamp Jun. 29 at 7:10 PM
$ABCL I'm anxiously awaiting the next two antibody programs we have, both haven't had their targets disclosed yet, but exciting times ahead!
0 · Reply
Ckkung71
Ckkung71 Jun. 29 at 6:54 PM
$ABCL Going for 15 million volume as Friday 👏
0 · Reply
WallStreetScoutt
WallStreetScoutt Jun. 29 at 6:06 PM
$ABCL is surging, trading at $8.20 (+11.11%). Strong volume and technical momentum suggest a potential breakout. Keep an eye on $8.30 for further upside.
2 · Reply
Odoji
Odoji Jun. 29 at 5:51 PM
$ABCL 💉
0 · Reply
Biker68
Biker68 Jun. 29 at 5:39 PM
$ABCL Sure, this will go down(a bit), but ever sinse the deal with Jazz was public $ABCL has been re-evaluated. And this is definatively not just retail! New trend will follow!
1 · Reply